Skip to Main Content

Paper Details

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
J Neurol Neurosurg Psychiatry
14
2020
Author NameAffiliation
Hanna ZimmermannExperimental and Clinical Research Center, Max Delbruck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Hanna ZimmermannNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Alexander U BrandtExperimental and Clinical Research Center, Max Delbruck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Alexander U BrandtNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Alexander U BrandtUniversity of California irvine
Joachim HavlaInstitute of Clinical Neuroimmunology, LMU-Hospital
Friedemann PaulExperimental and Clinical Research Center, Max Delbruck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Friedemann PaulNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Friedemann PaulEinstein Center for Neurosciences
Friedemann PaulCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
  • 1 - 10

Datasets